Veer Bhavnagri has sold ALLO and made no open-market buys since Aug 2020
General Counsel at Allogene Therapeutics, Inc.
SEC CIK 0001808980 · Filings on SEC.gov ↗
Every filing
14 filings since Aug 2020, newest first
Allogene Therapeutics, Inc.
General Counsel
Allogene Therapeutics, Inc.
General Counsel
Allogene Therapeutics, Inc.
General Counsel
Allogene Therapeutics, Inc.
General Counsel
Allogene Therapeutics, Inc.
General Counsel
Allogene Therapeutics, Inc.
General Counsel
Allogene Therapeutics, Inc.
General Counsel
Allogene Therapeutics, Inc.
General Counsel
Allogene Therapeutics, Inc.
General Counsel
Allogene Therapeutics, Inc.
General Counsel
Allogene Therapeutics, Inc.
General Counsel
Allogene Therapeutics, Inc.
General Counsel
Allogene Therapeutics, Inc.
General Counsel
Allogene Therapeutics, Inc.
General Counsel
Filings come from SEC EDGAR. Not investment advice.